No Sugar Added? The Hidden Food Additive Sweeping the Nation

Sucralose, “Zero Sugar” Marketing, and the Business Behind America’s New Sweetener Habit

Walk down almost any grocery aisle today and the labels sound reassuring: “no sugar added,” “zero sugar,” “low carb,” “keto friendly,” “diabetic friendly,” “light,” “reduced calorie,” and “guilt free.” But a closer look at the ingredient list often reveals what the front label leaves out: sucralose.

Sucralose is the artificial sweetener best known by the brand name Splenda. It is not sugar. It is a synthetic, high-intensity sweetener that the FDA says is about 600 times sweeter than table sugar. The FDA approved sucralose for 15 food categories in 1998, then approved it as a general-purpose sweetener in 1999. Today, the FDA identifies sucralose as a general-purpose sweetener found in baked goods, beverages, chewing gum, gelatins, and frozen dairy desserts.

That means sucralose is not legally “experimental.” But consumers are right to ask whether the country is living through a kind of post-market, real-world exposure experiment. The original regulatory approvals were based on defined uses, toxicology studies, estimated daily intake, and acceptable daily intake limits. They did not fully mirror the modern shopping cart, where a person might consume sucralose in a protein shake at breakfast, a “light” yogurt at lunch, a zero-sugar sports drink in the afternoon, sugar-free gum in the car, and a low-carb dessert after dinner.

The front label is where the marketing happens. The ingredient list is where the truth usually appears.

Under federal labeling rules, “no sugar added” does not mean the product is unsweetened. It means no sugars, or sugar-containing ingredients that substitute for added sugars, were added during processing or packaging. It does not mean the product is free of artificial sweeteners. It does not mean the product is a whole food. The rule is about sugar, not about the absence of sweetness.

That gap between the front label and the ingredient list is where sucralose has found its opening.

What Is Actually Owned?

The first thing consumers need to understand is that no single company owns sucralose as a chemical in the ordinary sense anymore. The original product patent on sucralose has expired, which opened the door for competitors and generic producers. However, companies still own trademarks, production processes, formulations, supply contracts, customer relationships, and retail brands. That is where the money is.

There are three separate layers:

First, there is the chemical compound: sucralose. That is the sweetener molecule itself.

Second, there is the consumer brand: Splenda. This is the yellow-packet household name that many consumers associate with sucralose.

Third, there is the industrial ingredient business: the business-to-business sale of sucralose and sweetener systems to major food and beverage manufacturers.

Those layers are not all controlled by the same company.

Who Owns Splenda Now?

The Splenda consumer brand is no longer owned by Johnson & Johnson. Johnson & Johnson Consumer Inc. completed the divestiture of the SPLENDA brand to Heartland Food Products Group in 2015. J&J disclosed that global sales for the SPLENDA brand were approximately $370 million in 2014, and the financial terms of the sale were not disclosed.

Heartland Food Products Group, based in the Indianapolis area, now owns the Splenda brand. Heartland says it completed the acquisition of the SPLENDA brand from Johnson & Johnson in October 2015 and, as a result, became “the global leader in all tabletop sweeteners through all channels of trade.”

This matters because most shoppers use the word “Splenda” as if it means sucralose itself. But Splenda is a brand. Sucralose is the chemical sweetener. A store-brand yellow packet may contain sucralose without being Splenda. A food product may contain sucralose without using the Splenda brand at all. And Splenda-branded products now include more than just original sucralose products, including stevia, monk fruit, allulose, creamers, and other reduced-sugar products.

Who Makes the Industrial Ingredient?

Tate & Lyle remains the central historic name behind industrial sucralose. The company markets SPLENDA® Sucralose as an ingredient for food and beverage manufacturers. Tate & Lyle says it is the sole manufacturer of SPLENDA® Sucralose, not necessarily the sole manufacturer of all sucralose globally. That distinction is important. The branded industrial ingredient is different from the generic chemical market. Tate & Lyle promotes SPLENDA® Sucralose as sugar-like, stable, versatile, heat-stable, and useful in beverages, dairy, confectionery, and “no added sugars,” “sugar free,” “diet,” and “sugar-reduced” product formulations.

Tate & Lyle also makes clear why food companies want this ingredient. There is pressure to reduce sugar and calories while keeping costs down, and consumers are not prepared to compromise on taste. That is the business formula in one sentence: less sugar on the label, familiar sweetness on the tongue, lower reformulation risk for the manufacturer.

The Big 2026 Business Move: Ingredion and Tate & Lyle

The ownership picture is now changing again. On June 8, 2026, Ingredion announced a recommended all-cash offer to acquire Tate & Lyle. The transaction values Tate & Lyle at an enterprise value of approximately £3.7 billion, or about $5 billion, and would combine two major food-ingredient companies with overlapping interests in texture, sweetening, sugar reduction, mouthfeel, and fortification.

Ingredion is not a small player. It is a publicly traded company listed on the New York Stock Exchange under the ticker INGR. Ingredion says it serves customers in more than 120 countries and reported approximately $7.2 billion in 2025 annual net sales, turning grains, fruits, vegetables, and other plant-based materials into ingredients for food, beverage, animal nutrition, brewing, and industrial markets.

The deal is not just about sucralose. It is about the larger business of reformulating the modern food supply. Ingredion says the acquisition would broaden its specialty ingredient platform across texturants, sugar reduction, and fortification, while combining Ingredion’s texture and sugar-reduction capabilities with Tate & Lyle’s expertise in mouthfeel, sweetening, and fortification.

That is the business side consumers rarely see. Companies are not simply replacing sugar with a single sweetener. They are rebuilding products. Sugar does more than sweeten. It affects browning, bulk, texture, mouthfeel, moisture, preservation, and consumer satisfaction. When sugar is removed, food scientists often have to replace not only the sweetness, but also the body and eating experience of sugar.

That means the “zero sugar” aisle is not just a health aisle. It is a food-engineering aisle.

J.M. Huber’s Role

Another major name in the ownership picture is J.M. Huber Corporation, one of the largest family-owned businesses in the United States. Huber sold CP Kelco to Tate & Lyle in 2024 and became a shareholder with about 16 percent ownership in Tate & Lyle.

By January 2026, Tate & Lyle described Huber as its largest shareholder and said Huber was entitled to nominate two non-executive directors for as long as it held at least 15 percent of Tate & Lyle’s ordinary shares.

In the June 2026 Ingredion acquisition announcement, Ingredion said it had received an irrevocable undertaking from Huber Equity Corporation to vote in favor of the acquisition, covering 75 million Tate & Lyle shares, representing approximately 16.8 percent of Tate & Lyle’s existing issued ordinary share capital as of June 5, 2026.

That means one of the most important shareholders in Tate & Lyle is already aligned with the Ingredion deal.

Public Companies, Institutional Owners, and Real Control

Ingredion is publicly traded, so its ownership is spread across shareholders. That does not mean no one has influence. Public-company control often flows through large institutional shareholders, boards, executives, and major asset managers.

Ingredion’s 2026 proxy statement reported 63,054,170 shares outstanding as of March 23, 2026. It listed BlackRock Inc. as a beneficial owner of more than 5 percent, with 6,566,730 shares, or 10.4 percent of the class. The same proxy reported that Ingredion’s directors and executive officers as a group held about 1.6 percent.

That is the modern corporate-food structure. The food additives themselves may be consumed by ordinary families, children, athletes, diabetics, and dieters, but the business decisions are made by multinational ingredient companies, brand owners, private firms, institutional shareholders, and large packaged-food customers.

The Global Supply Chain: Not Just One Company

The sucralose business is now global. Market research estimates the global sucralose market at about $1.21 billion in 2024, with projections of about $1.66 billion by 2030. The same report identifies key players including JK Sucralose, Tate & Lyle, Niutang Chemical, Ingredion, and Hubei Yitai, and estimates that China accounts for more than 75 percent of global sucralose manufacturing capacity.

That does not mean every product on an American shelf uses Chinese-made sucralose. It does mean the economics of sucralose are no longer just a Western brand story. They are part of a global ingredient market shaped by commodity pricing, patented processes, generic competition, food reformulation, import supply chains, and industrial-scale manufacturing.

When consumers see “sucralose” on an ingredient label, they usually cannot tell who made it, where it was manufactured, which supplier sold it, or how it moved through the food-production chain.

That is one of the central transparency problems.

Why Food Companies Use It

The reason is simple: sucralose solves a business problem.

Sugar adds calories, raises the “added sugar” number on the Nutrition Facts panel, and is increasingly criticized by doctors, parents, schools, insurers, and public-health agencies. But sweetness sells. Sucralose allows a company to remove much of the sugar while keeping the sweet taste consumers expect.

It is cheap in use because it is so potent. It is shelf-stable. It blends well with other sweeteners. It survives many processing conditions. The FDA also describes sucralose as heat stable, which makes it suitable for baking and other high-temperature food uses.

For the manufacturer, the incentive is powerful. A company can reduce sugar, lower calories, make a front-label claim, appeal to diabetics or dieters, avoid some sugar-tax pressures, and keep the product sweet.

That is not a conspiracy. It is a business model.

The “No Sugar Added” Sales Funnel

The modern food aisle works like this:

First, public health officials warn about sugar.

Second, consumers look for lower-sugar foods.

Third, food companies reformulate products to reduce sugar while preserving sweetness.

Fourth, packaging highlights “zero sugar,” “no sugar added,” or “low sugar.”

Fifth, consumers buy the product believing it is healthier.

Sixth, the ingredient list quietly carries the real story: sucralose, acesulfame potassium, maltodextrin, dextrose, sugar alcohols, modified starches, fibers, gums, flavors, and other formulation tools.

The result is a consumer shell game. Sugar may be reduced, but sweetness remains constant. The body may be spared some sugar calories, but the palate is never retrained away from hyper-sweet foods.

This is why sucralose is not merely an ingredient. It is part of a larger food-industry strategy.

Where Sucralose Is Showing Up

Sucralose is especially common in products designed to taste sweet while claiming low sugar or low calories. It appears in diet drinks, flavored waters, sports drinks, protein bars, protein shakes, light yogurts, sugar-free syrups, candies, gums, mints, gelatin desserts, “keto” snacks, meal-replacement shakes, and tabletop sweeteners.

It is also moving beyond obvious diet foods. Market research describes sucralose use in beverages, baked goods, dairy, confectionery, pharmaceuticals, and personal care. That means consumers may encounter it not only in drinks and snacks, but also in chewable tablets, oral suspensions, toothpaste, and other products where sweetness or taste-masking matters.

This is where the “real-world testing” concern becomes understandable. The average consumer is not reading every ingredient label across every exposure point. A child may encounter sucralose in a drink, a snack, a medication, and a dessert without the parent realizing the same sweetener is being repeated.

What Regulators Say

The FDA still considers sucralose safe under approved conditions of use. The agency says it reviewed more than 110 studies designed to identify possible toxic effects, including studies on reproductive and nervous system effects, carcinogenicity, metabolism, and human clinical trials involving diabetes.

That is the legal baseline. But legal approval is not the same as saying a product is nutritionally ideal, necessary, or wise as a daily habit.

The strongest consumer concern is not that one diet drink will poison someone. That is not what the evidence shows.

The more serious concern is repeated exposure, lifelong habit formation, altered expectations of sweetness, and the possibility that non-sugar sweeteners may not deliver the health benefits consumers think they are buying.

The Health Questions

Research on sucralose remains contested. Some studies and regulators support its safety within acceptable intake limits. Other studies raise questions about gut microbiome changes, glycemic response, intestinal barrier effects, and possible effects in specific medical situations.

The key point for consumers is that sucralose is not food in the traditional sense. It is a synthetic sweetening additive used to preserve sweetness while avoiding sugar, calories, and added-sugar label penalties.

It should be treated as an additive, not a health food.

A consumer who uses sucralose occasionally is in a different position than a consumer who unknowingly consumes it multiple times a day through drinks, snacks, powders, desserts, and “healthy” processed foods.

The Business Incentive No One Talks About

The food industry has a strong incentive to keep sweetness high. Sweetness drives repeat purchasing. It helps mask bitterness, acidity, mineral flavors, protein notes, and other off-flavors common in “better-for-you” products. It also allows companies to sell diet, keto, diabetic-friendly, and low-calorie products without forcing consumers to accept truly less-sweet foods.

That is why the business is not simply about sucralose. It is about formulation systems.

A “zero sugar” drink may use sucralose with acesulfame potassium. A protein bar may combine sucralose with sugar alcohols and fibers. A yogurt may use sucralose, starches, gums, and flavors. A tabletop packet may contain sucralose plus bulking agents such as maltodextrin or dextrose.

The consumer sees one claim: “zero sugar.”

The manufacturer sees a complete technical system: sweetness, mouthfeel, cost, shelf life, label claim, regulatory compliance, and repeat purchase.

The Consumer Transparency Problem

The main problem is not that sucralose is illegal. It is not.

The problem is that consumers are being trained to trust front-label sugar claims without understanding the industrial substitution behind them.

“No sugar added” should trigger a question, not automatic trust.

The question should be: “What replaced the sugar?”

If the answer is whole fruit, plain dairy, or an actually unsweetened product, that is one thing. If the answer is sucralose, acesulfame potassium, maltodextrin, sugar alcohols, flavors, gums, and starches, that is another.

What Consumers Should Watch For

Look past the front label. The words to search for are:

Sucralose. Splenda. E955. Acesulfame potassium. Ace-K. Aspartame. Neotame. Saccharin. Sugar alcohols such as erythritol, maltitol, sorbitol, and xylitol. Allulose. Maltodextrin. Dextrose.

Not all of these are the same thing, but they often appear together in reformulated products. A product may have little sugar and still be engineered to taste intensely sweet.

Be especially alert in children’s snacks, sports drinks, protein products, yogurts, “keto” desserts, drink powders, flavored waters, sugar-free syrups, gums, mints, and meal-replacement shakes.

The Bottom Line

Sucralose is not sugar. It is not natural food. It is not automatically dangerous in a single serving, and it remains legal under FDA rules. But it is also not the health halo that “no sugar added” marketing suggests.

The food industry has found a profitable formula: remove sugar, keep sweetness, lower the number on the label, and sell the product as smarter, lighter, cleaner, or safer.

The business behind sucralose is now much larger than yellow packets on a restaurant table. It involves private brand owners, global ingredient manufacturers, institutional investors, multinational food companies, Chinese production capacity, patent history, trademarks, and a massive reformulation economy built around sugar reduction.

Consumers should not be fooled. A food can be “no sugar added” and still be highly processed. It can be “zero sugar” and still train the body and brain to expect constant sweetness. It can be “low carb” and still contain chemical sweeteners that researchers are still studying in the gut, metabolism, cardiovascular system, and immune response.

The safest consumer rule is simple: do not let the front label do your thinking. Turn the package around. Read the ingredient list. And remember that “no sugar added” does not always mean no problem added.

The US Government Sweetheart Deal: Big Sugar Gets the Deal, Sucralose Gets the Opening

The business story behind sucralose cannot be separated from the strange way the United States treats sugar.

Domestic sugar is not priced in a completely free market. The U.S. sugar program uses price supports, domestic marketing allotments, tariff-rate quotas, and high out-of-quota tariffs to control how much sugar reaches the American market. USDA’s Economic Research Service says this structure restricts sugar available to the U.S. market and supports U.S. sugar prices, which are usually well above comparable world prices.

That matters because high domestic sugar prices help create the economic opening for sugar substitutes. When sugar is expensive, politically protected, and increasingly criticized for its health effects, food companies have a strong incentive to find another way to keep products sweet.

Sucralose fits that business need. It is intensely sweet, FDA-approved, widely usable, and only a tiny amount is needed compared with ordinary sugar. The FDA says sucralose is about 600 times sweeter than sugar and was approved for 15 food categories in 1998 before being approved as a general-purpose sweetener in 1999.

This is not obvious to most consumers: sugar receives the more obvious government protection, but artificial sweeteners benefit from the market conditions that protection helps create.

The domestic sugar program is direct and formal. There are sugar loan rates. There are marketing allotments. There are import quotas. There are tariffs. There is also the Feedstock Flexibility Program, under which USDA can buy surplus sugar and sell it to bioenergy producers if necessary to avoid loan forfeitures. USDA announced in March 2026 that it did not currently expect to purchase and sell sugar under that program for crop year 2025, but the mechanism remains part of the federal sugar policy structure.

Sucralose and other artificial sweeteners do not appear to have an equivalent federal “sweetheart deal” in the same sense. There is no USDA sucralose loan rate. There is no sucralose marketing allotment. There is no sucralose quota system designed to hold domestic sucralose prices above the world market. There is no standing federal program requiring the government to buy surplus sucralose; however, it does not mean artificial sweeteners operate in a policy-free universe. Instead, they benefit from a different kind of advantage.

First, FDA approval gives them legal market access. Once a high-intensity sweetener is approved for food use, manufacturers can build entire product lines around it. That approval becomes the foundation for “zero sugar,” “no sugar added,” “low calorie,” and “diet” reformulations. The FDA identifies sucralose as a general-purpose sweetener used in baked goods, beverages, canned fruits, chewing gum, gelatins, and frozen dairy desserts.

Second, labeling rules let companies market the absence of sugar more loudly than the presence of the substitute. The front of the package may say “no sugar added.” The sucralose appears on the back, buried in the ingredient list. That is not the same as a subsidy, but it is a major commercial advantage. Can you imagine if the label read: "NOW with MORE Sucralose!"?

Third, trade policy can tilt the sweetener market. Some imported sweeteners may face tariffs, antidumping cases, or countervailing duties, while others may receive exemptions or more favorable treatment. A 2025 industry analysis reported that sucralose and acesulfame-K were exempted from certain new U.S. tariffs, giving them a strategic edge over some other sweeteners.

Fourth, the sugar program itself indirectly helps the sweetener industry. If domestic sugar costs more than it otherwise would in a freer market, then every high-intensity sweetener becomes more attractive to food manufacturers trying to reduce costs, lower calories, and make sugar-reduction claims.

This is the key distinction: sugar has the direct federal deal. Sucralose has the market opening created by that deal. SO, does every sweet-heart and sweet-tooth gets a piece of the pie?

For consumers, the result is the same aisle-level transformation. Sugar is politically protected on one side, attacked by health messaging on the other, and replaced by synthetic or alternative sweeteners in the middle. The food companies win big either way. It can reduce sugar, preserve sweetness, promote the product as healthier, and often avoid retraining consumers away from hyper-sweet sensory 'flavors'.

The stronger consumer question now is not simply, “Does sucralose get the same government deal as sugar?”...

The better question is: “Did federal sugar policy, FDA approval, labeling rules, and trade treatment combine to make artificial sweeteners the easy escape hatch for "Big 'Food'"?”

The answer appears to be, yes. Not through one obvious subsidy check, but through a system of specialized incentives. 

Sugar is protected. Sugar is expensive. Sugar is criticized. Sucralose is legal, powerful, cheap in use, and marketable under “zero sugar” language.

That is how the chemical sweetener industry found its way into the American grocery cart without needing the same kind of formal sweetheart deal that Florida sugar has enjoyed for decades.

Buyer Beware and Be Wise with your Healthcare... 

"No disease that can be treated by diet should be treated with any other means." — Maimonides, 12th-century philosopher and physician.